NCT01020136View on ClinicalTrials.gov

A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Healthy Volunteer
Interventions
DRUG

AG-013736

single oral dose 5-mg tablet (Form IV for Treatment A and Form XLI for Treatment B under fed conditions)

DRUG

AG-013736

single oral dose 5-mg tablet (Form IV for Treatment A and Form XLI for Treatment B under fed conditions)

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01020136 - A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers | Biotech Hunter | Biotech Hunter